The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities-Reference-Cited by-同舟云学术

The 340B Drug Discount Program: Hospitals Generate Profits By Expanding To Reach More Affluent Communities

Published:2014-10 Issue:10 Volume:33 Page:1786-1792
ISSN:0278-2715
Container-title:Health Affairs
language:en
Short-container-title:Health Affairs

Author:

Conti Rena M.¹,Bach Peter B.²

Affiliation:

1. Rena M. Conti ( ) is an assistant professor of health policy and economics in the Departments of Pediatrics and Health Studies at the University of Chicago, in Illinois.

2. Peter B. Bach is director of the Center for Health Policy and Outcomes at Memorial Sloan Kettering Cancer Center, in New York City.

Publisher

Health Affairs (Project Hope)

Subject

Health Policy

Reference13 articles.

1. Cost Consequences of the 340B Drug Discount Program

2. Hospitals’ Geographic Expansion In Quest Of Well-Insured Patients: Will The Outcome Be Better Care, More Cost, Or Both?

3. Vertical Integration: Hospital Ownership Of Physician Practices Is Associated With Higher Prices And Spending

4. Hospitals, Market Share, and Consolidation

5. Proportion Of Physicians In Large Group Practices Continued To Grow In 2009–11

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical Gaps in Ophthalmology in the United States;Clinical Ophthalmology;2024-09

2. Reforming 340B to Serve the Interests of Patients, Not Institutions;JAMA Health Forum;2024-07-26

3. Addressing financial toxicity in cancer treatment—An opportunity for the 340B drug pricing program;Cancer;2024-05-28

4. Community social vulnerability and the 340B Drug Pricing Program: Evaluating predictors of 340B participation among critical access hospital;The Journal of Rural Health;2024-03-23

5. The 340B Program and oral specialty drugs for advanced prostate cancer;Cancer;2024-02-23